Tharimmune, Inc. Files 8-K with Bylaw Amendments
Ticker: CNTN · Form: 8-K · Filed: Oct 10, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Oct 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
TL;DR
THARIMMUNE files 8-K for bylaw changes & financials.
AI Summary
On October 10, 2025, Tharimmune, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws and including financial statements and exhibits. The company, formerly known as Hillstream BioPharma Inc. until September 25, 2023, is incorporated in Delaware and has its principal executive offices in Red Bank, NJ.
Why It Matters
This filing indicates potential corporate governance changes and the submission of financial information, which are important for investors to understand the company's structure and financial health.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediately alarming information.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Hillstream BioPharma Inc. (company) — Former company name
- October 10, 2025 (date) — Date of report
- September 25, 2023 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Red Bank, NJ (location) — Principal executive offices
FAQ
What specific amendments were made to Tharimmune, Inc.'s Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What financial statements and exhibits are included in this 8-K filing?
The filing states that Financial Statements and Exhibits are included, but the specific content of these documents is not detailed in the provided excerpt.
When did Tharimmune, Inc. change its name from Hillstream BioPharma Inc.?
Tharimmune, Inc. changed its name from Hillstream BioPharma Inc. on September 25, 2023.
What is the principal executive office address for Tharimmune, Inc.?
The principal executive office address for Tharimmune, Inc. is 34 Shrewsbury Ave., Suite 1C, Red Bank, NJ 07701.
What is the SIC code for Tharimmune, Inc.?
The Standard Industrial Classification (SIC) code for Tharimmune, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-10-10 16:22:17
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex3-1.htm (EX-3.1) — 11KB
- 0001493152-25-017766.txt ( ) — 214KB
- thar-20251010.xsd (EX-101.SCH) — 3KB
- thar-20251010_lab.xml (EX-101.LAB) — 33KB
- thar-20251010_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 10, 2025 Tharimmune, Inc. /s/ Sireesh Appajosyula Sireesh Appajosyula Chief Executive Officer -3-